Prentiss Christopher B

Avg. Two Year Performance

No purchase track record

18% Avg. Sale Return

9% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(1%)	5%	12%	13%	18%
Sale Success Rate	4 of 8	6 of 8	7 of 8	5 of 8	4 of 8

Adamas Pharmaceuticals Inc

Drugs » Drugs - Generic

Chief Financial Officer:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--